Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Revolution Medicines (RVMD) Other Non Operating Income (2024 - 2026)

Revolution Medicines has reported Other Non Operating Income over the past 2 years, most recently at $1.3 million for Q4 2025.

  • For Q4 2025, Other Non Operating Income changed N/A year-over-year to $1.3 million; the TTM value through Dec 2025 reached $1.6 million, changed N/A, while the annual FY2025 figure was $1.3 million, N/A changed from the prior year.
  • Other Non Operating Income for Q4 2025 was $1.3 million at Revolution Medicines, up from -$10000.0 in the prior quarter.
  • Over five years, Other Non Operating Income peaked at $1.3 million in Q4 2025 and troughed at -$2.8 million in Q1 2024.